Technology
Health
Pharmaceutical

Acer

$3.05
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.04 (-1.29%) As of 12:38 PM EDT today
-$0.04 (-1.29%) Today

Why Robinhood?

You can buy or sell Acer and other stocks, options, ETFs, and crypto commission-free!

About ACER

Acer Therapeutics Inc. Common Stock (DE), also called Acer, is a pharmaceutical company, which engages in the acquisition, development, and commercialization of therapies for medical needs. Read More Its product pipeline includes Edsivo and ACER-001. The Edsivo is a type of celiprolol for Vascular Ehlers-Danlos syndrome. The ACER-001 is for the treatment of urea cycle disorders and Maple Syrup Urine diseases. The company was founded by Christopher Schelling in September 2017 and is headquartered in Newton, MA.

Employees
23
Headquarters
Newton, Massachusetts
Founded
2017
Market Cap
31.17M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
265.13K
High Today
$3.36
Low Today
$2.93
Open Price
$3.04
Volume
99.30K
52 Week High
$34.10
52 Week Low
$2.73

Collections

Technology
Health
Pharmaceutical
Therapy
Medical
US
North America

ACER News

BenzingaJul 2

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Acer Therapeutics, Inc.

251
MarketWatchJun 25

Acer Therapeutics receives CRL from FDA for Edsivo, stock halted for news

2,301

ACER Earnings

-$0.85
-$0.71
-$0.57
-$0.43
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 12, Pre-Market

More ACER News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.